Sanjiu Medical Kicks Off Industrial Park Operation
This article was originally published in PharmAsia News
Executive Summary
With the backing of main shareholder China Resources Enterprise, restructured Sanjiu Medical & Pharmaceutical has finished constructing its industrial park and begun operations. The 300-million-yuan phase one project, located in the city's Guanlan High Tech Area, occupies 110,000 square meters. Sanjiu will acquire another 70,000 square meters for phase two, earmarked for related pharmaceutical production and auxiliary facilities. According to CR Enterprise, Sanjiu will focus on OTC brands as its core business, with TCM prescription and free-decocting TCM as fast-growth areas. The firm will reorganize its antibiotics and generics business to enter the tier-three end-user market. The latest event marks a key milestone for CR Enterprise, which will base its pharmaceutical headquarters in Shenzhen to further boost the business. (Click here for more - Chinese Language)